Associate Professor Hesham Al-Sallami

2023

Journal - Research Article

Sergel-Stringer, O. T., Al-Sallami, H. S., Styles, S. E., Boucsein, A., de Bock, M. I., & Wheeler, B. J. (2023). Knowledge, safety, and impact of alcohol consumption in young adults with type 1 diabetes mellitus: A qualitative study. BMC Endocrine Disorders, 23, 229. doi: 10.1186/s12902-023-01471-7

O'Hanlon, C. J., Holford, N., Sumpter, A., & Al-Sallami, H. S. (2023). Consistent methods for fat free mass, creatinine clearance and glomerular filtration rate to describe renal function from neonates to adults. Clinical & Translational Science, 12, 12924, 401-412. doi: 10.1002/psp4.12924

Conference Contribution - Published proceedings: Abstract

Chung, A., Wheeler, B. J., & Al-Sallami, H. S. (2023). The effect of alcohol consumption on blood glucose in young adults with type 1 diabetes mellitus. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. P507. Retrieved from https://www.asceptasm.com

Sergel-Stringer, O. T., Al-Sallami, H. S., Styles, S. E., Boucsein, A., de Bock, M., & Wheeler, B. J. (2023). Knowledge, safety, and impact of alcohol consumption in young adults with type 1 diabetes mellitus: A qualitative study. Proceedings of the 46th New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting. Poster 1. Retrieved from https://www.nzssd.org.nz/home.html

2022

Journal - Research Article

Derbalah, A., Duffull, S., Sherwin, C. M., Job, K., & Al-Sallami, H. (2022). Optimal dosing of enoxaparin in overweight and obese children. British Journal of Clinical Pharmacology, 88, 5348-5358. doi: 10.1111/bcp.15459

Journal - Research Other

Al-Sallami, H. S., Wright, D. F. B., & Duffull, S. B. (2022). The propagation of between-subject variability from dose to response. British Journal of Clinical Pharmacology, 88, 1414-1417. doi: 10.1111/bcp.14699

Derbalah, A., Al-Sallami, H., Hasegawa, C., Gulati, A., & Duffull, S. B. (2022). A framework for simplification of quantitative systems pharmacology models in clinical pharmacology. British Journal of Clinical Pharmacology, 88, 1430-1440. doi: 10.1111/bcp.14451

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H. S. (2022). Between patient variability in drug disposition of large vs small molecules. Proceedings of the Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Conference. 526. Retrieved from https://www.asceptasm.com

Conference Contribution - Verbal presentation and other Conference outputs

Lim, I., Wheeler, B. J., & Al-Sallami, H. S. (2022, August-September). Optimal insulin initiation dose in children with type 1 diabetes mellitus. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.

2021

Journal - Research Article

Santiago, M., Davis, E. A., Hinton, T., Angelo, T. A., Shield, A., Babey, A.-M., … Al-Sallami, H. S., … White, P. J. (2021). Defining and unpacking the core concepts of pharmacology education. Pharmacology Research & Perspectives, 9(6), e00894. doi: 10.1002/prp2.894

White, P. J., Davis, E. A., Santiago, M., Angelo, T., Shield, A., Babey, A.-M., … Al-Sallami, H. S., … Hinton, T. (2021). Identifying the core concepts of pharmacology education. Pharmacology Research & Perspectives, 9(4), e00836. doi: 10.1002/prp2.836

Majimbi, M., Brook, E., Galettis, P., Eden, E., Al-Salami, H., Mooranian, A., Al-Sallami, H., … Takechi, R. (2021). Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid. PLoS ONE, 16(6), e0243858. doi: 10.1371/journal.pone.0243858

Derbalah, A., Al-Sallami, H. S., & Duffull, S. B. (2021). Reduction of quantitative systems pharmacology models using artificial neural networks. Journal of Pharmacokinetics & Pharmacodynamics, 48, 509-523. doi: 10.1007/s10928-021-09742-3

Derbalah, A., Duffull, S., Moynihan, K., & Al-Sallami, H. (2021). The influence of haemostatic system maturation on the dose-response relationship of unfractionated heparin. Clinical Pharmacokinetics, 60, 491-499. doi: 10.1007/s40262-020-00949-0

Bahnasawy, S., Al-Sallami, H., & Duffull, S. (2021). A minimal model to describe short-term haemodynamic changes of the cardiovascular system. British Journal of Clinical Pharmacology, 87, 1411-1421. doi: 10.1111/bcp.14541

2020

Journal - Research Article

Sinha, J., Al-Sallami, H. S., & Duffull, S. B. (2020). An extension of Janmahasatian’s Fat-Free Mass model for universal application across populations of different ethnicities. Clinical Pharmacokinetics, 59, 1161-1170. doi: 10.1007/s40262-020-00883-1

Mooranian, A., Wagle, S. R., Kovacevic, B., Takechi, R., Mamo, J., Lam, V., … Al-Sallami, H., & Al-Salami, H. (2020). Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. Scientific Reports, 10, 106. doi: 10.1038/s41598-019-53999-1

Sinha, J., Duffull, S. B., Green, B., & Al-Sallami, H. S. (2020). Evaluating the relationship between lean liver volume and fat-free mass. Clinical Pharmacokinetics, 59, 475-483. doi: 10.1007/s40262-019-00824-7

Journal - Research Other

Sinha, J., Al-Sallami, H. S., & Duffull, S. B. (2020). Authors' reply to Friesen: "An extension of Janmahasatian's Fat-Free Mass Model for universal application across populations of different ethnicities". Clinical Pharmacokinetics, 59, 1315. doi: 10.1007/s40262-020-00906-x

Sinha, J., Duffull, S. B., Green, B., & Al-Sallami, H. S. (2020). Evaluating lean liver volume as a potential scaler for in vitro-in vivo extrapolation of drug clearance in obesity using the model drug antipyrine. Current Drug Metabolism, 21(10), 746-750. doi: 10.2174/1389200221666200515105800

Conference Contribution - Published proceedings: Abstract

Derbalah, A., Duffull, S., Moynihan, K., & Al-Sallami, H. (2020). The influence of haemostatic system maturation on the dose-response relationship of unfractionated heparin. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Science Association (APSA) Joint Scientific Meeting: Global Solutions for Global Challenges. Retrieved from https://www.asceptasm.com/2020-annual-scientific-meeting

2019

Journal - Research Article

Mooranian, A., Zamani, N., Luna, G., Al-Sallami, H., Mikov, M., Goločorbin-Kon, S., … Al-Salami, H. (2019). Bile acid-polymer-probucol microparticles: Protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine mode. Pharmaceutical Development & Technology, 24(10), 1272-1277. doi: 10.1080/10837450.2019.1665069

Abdul Aziz, Y. H., Al-Sallami, H. S., Wiltshire, E., Rayns, J., Willis, J., McClintock, J., Medlicott, N., Wheeler, B. J., the Paediatric Society of New Zealand Diabetes Clinical Network. (2019). Insulin pump initiation and education for children and adolescents: A qualitative study of current practice in New Zealand. Journal of Diabetes & Metabolic Disorders, 18, 59-64. doi: 10.1007/s40200-019-00390-6

Majid, A., Blackwell, M., Broadbent, R. S., Barker, D. P., Al-Sallami, H. S., Edmonds, L., Kerruish, N., & Wheeler, B. J. (2019). Newborn vitamin K prophylaxis: A historical perspective to understand modern barriers to uptake. Hospital Pediatrics, 9(1), 55-60. doi: 10.1542/hpeds.2018-0104

Sinha, J., Al-Sallami, H. S., & Duffull, S. B. (2019). Choosing the allometric exponent in covariate model building. Clinical Pharmacokinetics, 28(1), 89-100. doi: 10.1007/s40262-018-0667-0

Dowd, L. A., Wheeler, B. J., Al-Sallami, H. S., Broadbent, R. S., Edmonds, L. K., & Medlicott, N. J. (2019). Paracetamol treatment for patent ductus arteriosus: Practice and attitudes in Australia and New Zealand. Journal of Maternal-Fetal & Neonatal Medicine, 32(18), 3039-3044. doi: 10.1080/14767058.2018.1456520

Journal - Research Other

Mooranian, A., Zamani, N., Takechi, R., Al-Sallami, H., Mikov, M., Goločorbin-Kon, S., … Al-Salami, H. (2019). Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice. Therapeutic Delivery, 10(9), 563-571. doi: 10.4155/tde-2019-0052

Hennig, S., Hannam, J. A., Kirkpatrick, C. M. J., Staatz, C. E., Holford, S., Duffull, S. B., Al-Sallami, H. S., … Foster, D. J. R. (2019). Pharmacometrics in Australasia: Twenty years of Population Approach Group of Australia and New Zealand. CPT: Pharmacometrics & Systems Pharmacology, 8(10), 701-704. doi: 10.1002/psp4.12460

Derbalah, A., Duffull, S., Newall, F., Moynihan, K., & Al-Sallami, H. (2019). Revisiting the pharmacology of unfractionated heparin. Clinical Pharmacokinetics, 58(8), 1015-1028. doi: 10.1007/s40262-019-00751-7

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H. (2019). The principles of dosing, response variability, and dose individualisation challenges in children. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 42). Retrieved from https://www.asceptasm.com

Sinha, J., Al-Sallami, H., Green, B., & Duffull, S. (2019). An extension of Janmahasatian's fat-free mass model to incorporate differences due to ethnicity. Proceedings of the 20th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). (pp. 41-42). Retrieved from https://www.paganz.org/auckland-2019

Bahnasawy, S., Al-Sallami, H., Barrett, J., & Duffull, S. (2019). An ePKPD model for sodium nitroprusside in adolescents. Proceedings of the 20th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). (pp. 35-36). Retrieved from https://www.paganz.org/auckland-2019

Derbalah, A., Duffull, S., & Al-Sallami, H. (2019). Quantifying the does-response of unfractionated heparin using a system pharmacology model of coagulation. Proceedings of the 20th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). (pp. 6-7). Retrieved from https://www.paganz.org/auckland-2019

Sinha, J., Al-Sallami, H., & Duffull, S. (2019). Extension of the Janmahasatian fat-free mass model to account for ethnicity-related bias. Proceedings of the Twenty-Eighth Annual Meeting of the Population Approach Group in Europe (PAGE). (pp. 410-411). Retrieved from https://www.page-meeting.org

Al-Sallami, H. S., Schollum, J., Barras, M., & Duffull, S. B. (2019). The use of a Bayesian dosing tool to optimise enoxaparin treatment: A pilot clinical study. Proceedings of the Twenty-Eighth Annual Meeting of the Population Approach Group in Europe (PAGE). (pp. 40-41). Retrieved from https://www.page-meeting.org

2018

Journal - Research Article

Mooranian, A., Zamani, N., Takechi, R., Al-Sallami, H., Mikov, M., Goločorbin-Kon, S., … Al-Salami, H. (2018). Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes. Artificial Cells, Nanomedicine & Biotechnology, 46(Suppl. 3), S748-S754. doi: 10.1080/21691401.2018.1511572

Muller, M., Wheeler, B. J., Blackwell, M., Colas, M., Reith, D. M., Medlicott, N. J., & Al-Sallami, H. S. (2018). The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus. Journal of Diabetes & Metabolic Disorders, 17, 159-163. doi: 10.1007/s40200-018-0355-5

Al-Sallami, H., & Loke, S.-K. (2018). Learning a complex dose–response relationship with the computer simulation CoaguSim. Currents in Pharmacy Teaching & Learning, 10, 1406-1413. doi: 10.1016/j.cptl.2018.07.009

Mooranian, A., Negrulj, R., Takechi, R., Mamo, J., Al-Sallami, H., & Al-Salami, H. (2018). The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: Potential hypoglycaemic and anti-inflammatory effects. Drug Delivery & Translational Research, 8(3), 543-551. doi: 10.1007/s13346-017-0473-5

Journal - Research Other

Reith, D. M., & Al-Sallami, H. S. (2018). Comment on van Rongen et al., "Higher midazolam clearance in obese adolescents compared with morbidly obese adults". Clinical Pharmacokinetics, 57, 1355. doi: 10.1007/s40262-018-0691-0

Sinha, J., Duffull, S. B., & Al-Sallami, H. S. (2018). A review of the methods and associated mathematical models used in the measurement of fat-free mass. Clinical Pharmacokinetics, 57(7), 781-795. doi: 10.1007/s40262-017-0622-5

Conference Contribution - Published proceedings: Abstract

Gandhi, P., Wheeler, B. J., Edmonds, L., Medlicott, N., Broadbent, R., & Al-Sallami, H. S. (2018). How is neonatal hyperglycaemia treated in NICUs across Australia and New Zealand? Journal of Paediatrics & Child Health, 54(Suppl. 1), (pp. 75-76). doi: 10.1111/jpc.13881

Sinha, J., Duffull, S., Green, B., & Al-Sallami, H. (2018). Development of a model to predict lean liver volume (LLV) for use in scaling drug clearance. Proceedings of the 19th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://paganz.org

Sinha, J., Duffull, S., Green, B., Ponnuswamy, T., Devanand, B., Ramanathan, M., … Al-Sallami, H. (2018). Development of a model to predict lean liver volume (LLV) for use in scaling drug clearance. Journal of Pharmacokinetics & Pharmacodynamics, 45(Suppl. 1), (pp. S52-S53). doi: 10.1007/s10928-018-9606-9

Conference Contribution - Verbal presentation and other Conference outputs

Sinha, J., Duffull, S., Green, B., Ponnuswamy, T. K., Devanand, B., Ramanathan, M., … Al-Sallami, H. (2018, August). Development of predictive model for lean liver volume, a potential scaler for in vitro-in vivo extrapolation of drug clearance. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2017

Journal - Research Article

Selvakumar, D., Al-Sallami, H. S., de Bock, M., Ambler, G. R., Benitez-Aguirre, P., Wiltshire, E., … Willis, J., Wheeler, B. J., on behalf of the Paediatric Society of New Zealand Diabetes Clinical Network. (2017). Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: A survey of current practice. Journal of Paediatrics & Child Health, 53(12), 1208-1214. doi: 10.1111/jpc.13631

Gogoi-Tiwari, J., Williams, V., Waryah, C. B., Costantino, P., Al-Salami, H., Mathavan, S., … Al-Sallami, H., & Mukkur, T. (2017). Mammary gland pathology subsequent to acute infection with strong versus weak biofilm forming Staphylococcus aureus bovine mastitis isolates: A pilot study using non-invasive mouse mastitis model. PLoS ONE, 12(1), e0170668. doi: 10.1371/journal.pone.0170668

Conference Contribution - Published proceedings: Abstract

Gandhi, P., Wheeler, B., Edmonds, L., Medlicott, N., Broadbent, R., Reith, D., & Al-Sallami, H. (2017). Neonatal hyperglycaemia management: Current practice in Australia and New Zealand. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 27). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html

Dowd, L., Wheeler, B., Al-Sallami, H., Broadbent, R., Edmonds, L., Reith, D., & Medlicott, N. (2017). Paracetamol treatment for patent ductus arteriosus: Current clinical practices and attitudes. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 19-20). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html

Al-Sallami, H. S., Anakin, M., Smith, A., Peterson, A., & Duffull, S. B. (2017). Experiences in defining Entrustable Professional Activities to drive the learning of undergraduate pharmacy students. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 21). Retrieved from http://www.asceptasm.com/

Conference Contribution - Verbal presentation and other Conference outputs

Sinha, J., Al-Sallami, H. S., & Duffull, S. B. (2017, September). Influence of clinical study design on ensuring accurate scaling of dose to patients. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2016

Journal - Research Article

Al-Sallami, H., Newall, F., Monagle, P., Ignjatovic, V., Cranswick, N., & Duffull, S. (2016). Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients. British Journal of Clinical Pharmacology, 82(1), 178-184. doi: 10.1111/bcp.12930

Negrulj, R., Mooranian, A., Chen-Tan, N., Al-Sallami, H. S., Mikov, M., Golocorbin-Kon, S., … Al-Salami, H. (2016). Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artificial Cells, Nanomedicine & Biotechnology, 44(5), 1290-1297. doi: 10.3109/21691401.2015.1024845

Tordoff, J. M., Ailabouni, N. J., Browne, D. P., Al-Sallami, H. S., & Gray, A. R. (2016). Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand. International Journal of Clinical Pharmacy, 38(4), 941-949. doi: 10.1007/s11096-016-0318-1

Conference Contribution - Published proceedings: Full paper

Al-Sallami, H., & Loke, S.-K. (2016). Using a coagulation simulation software to learn a complex dose-response relationship. In N. Wright (Ed.), Proceedings of the Distance Education Association New Zealand (DEANZ) Conference: There and Back: Charting Flexible Pathways in Open, Mobile and Distance Education. (pp. 130-133). Retrieved from http://conference.deanz.org.nz/

Conference Contribution - Published proceedings: Abstract

Anakin, M., & Al-Sallami, H. (2016). An undergraduate pharmacy curriculum anchored to Entrustable Professional Activities. Proceedings of the Tertiary Education Research in New Zealand (TERNZ) Conference. Retrieved from http://herdsa.org.nz/ternz/2016

Selvakumar, D., Al-Sallami, H. S., de Bock, M., Ambler, G. R., Benitez Agguire, P., Wiltshire, E., … Willis, J., & Wheeler, B. J. (2016). Insulin regimes for newly diagnosed children with Type 1 diabetes in Australia and New Zealand: A survey of current practice. Proceedings of the Australasian Paediatric Endocrine Group Conference. Retrieved from https://willorganise.eventsair.com/QuickEventWebsitePortal/2016-apeg-conference/website

Abdul Aziz, Y., Al-Sallami, H., Wiltshire, E., Willis, J., Rayns, J., McClintock, J., Medlicott, N., & Wheeler, B. (2016). Insulin pump initiation and education: Current paediatric practice in Australia and New Zealand. Proceedings of the Australasian Paediatric Endocrine Group Conference. Retrieved from https://willorganise.eventsair.com/QuickEventWebsitePortal/2016-apeg-conference/website

Al-Sallami, H. S. (2016). Drug dosing and between-subject variability. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 34). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/

Al-Sallami, H. S. (2016). Redefining normal variability of drug disposition. Proceedings of the Twenty-Fifth Annual Meeting of the Population Approach Group in Europe (PAGE). (pp. 172). Retrieved from http://www.page-meeting.org/

2015

Journal - Research Article

Mooranian, A., Negrulj, R., Al-Sallami, H. S., Fang, Z., Mikov, M., Golocorbin-Kon, S., … Al-Salami, H. (2015). Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes. AAPS PharmSciTech, 16(1), 45-52. doi: 10.1208/s12249-014-0205-9

Mooranian, A., Negrulj, R., Al-Sallami, H. S., Fang, Z., Mikov, M., Golocorbin-Kon, S., … Al-Salami, H. (2015). Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. Journal of Microencapsulation, 32(2), 151-156. doi: 10.3109/02652048.2014.958204

Al-Sallami, H. S., Goulding, A., Grant, A., Taylor, R., Holford, N., & Duffull, S. B. (2015). Prediction of fat-free mass in children. Clinical Pharmacokinetics, 54(11), 1169-1178. doi: 10.1007/s40262-015-0277-z

Al-Sallami, H. S., & Medlicott, N. J. (2015). Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasma. Journal of Pharmacy & Pharmacology, 67(2), 209-214. doi: 10.1111/jphp.12333

Conference Contribution - Published proceedings: Abstract

Tordoff, J., Ailabouni, N., Browne, D., Al-Sallami, H., & Gray, A. (2015). Changes in antipsychotic prescribing in dementia and psychogeriatric units in New Zealand. International Journal of Clinical Pharmacy, 37(Suppl. 1), (pp. 4). doi: 10.1007/s11096-015-0121-4

Yu, F. J., Milne, T., Knight, J., Grant, C. C., & Al-Sallami, H. S. (2015). Exploring the influence of patient covariates on the dose-response of vitamin D supplementation in pregnant women and their infants. New Zealand Medical Journal, 128(1427). Retrieved from http://www.nzma.org.nz/journal

Al-Sallami, H. S. (2015). Dosing in children and the need to account for body composition. Proceedings of the New Zealand Hospital Pharmacists' Association (NZHPA) Annual Conference. (pp. 57). Retrieved from http://www.nzhpa.org.nz/conferences--meetings.aspx

Al-Sallami, H. S., Newall, F., Monagle, P., Ignajatovic, V., Cranswick, N., & Duffull, S. (2015). Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients. Proceedings of the Twenty-Fourth Annual Meeting of the Population Approach Group in Europe (PAGE). 3448. Retrieved from http://www.page-meeting.org/

Conference Contribution - Verbal presentation and other Conference outputs

Yu, F. J., Milne, T., Knight, J., Grant, C. C., & Al-Sallami, H. S. (2015, September). Exploring the influence of patient covariates on the dose-response of vitamin D supplementation in pregnant women and their infants. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Al-Sallami, H. S., Newall, F., Monagle, P., Ignjatovic, V., Cranswick, N., & Duffull, S. B. (2015, September). The influence of body composition on the dose-response of heparin in children. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Al-Sallami, H. (2015, January). Redefining normal variability of drug disposition. Verbal presentation at the 17th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ), Melbourne, Australia.

Al-Sallami, H., & Wright, D. (2015, January). Hands on with NONMEM II: Covariate models. Workshop presentation at the 17th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ), Melbourne, Australia.

Al-Sallami, H. (2015, January). Building structural models. Workshop presentation at the 17th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ), Melbourne, Australia.

Al-Sallami, H., & Wright, D. (2015, January). Hands on with NONMEM: Residual variance models. Workshop presentation at the 17th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ), Melbourne, Australia.

2014

Journal - Research Article

Mooranian, A., Negrulj, R., Chen-Tan, N., Al-Sallami, H. S., Fang, Z., Mukkur, T. K., Mikov, M., … Al-Salami, H. (2014). Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Design, Development & Therapy, 8, 1221-1230. doi: 10.2147/dddt.s67349

Mooranian, A., Negrulj, R., Chen-Tan, N., Al-Sallami, H. S., Fang, Z., Mukkur, T., Mikov, M., … Al-Salami, H. (2014). Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study. Drug Design, Development & Therapy, 8, 1003-1012. doi: 10.2147/dddt.s65396

Journal - Research Other

Al-Sallami, H. S., Cheah, S. L., Han, S. Y., Liew, J., Lim, J., Ng, M. A., Solanki, H., Soo, R. J., Tan, V., & Duffull, S. B. (2014). Between-subject variability: Should high be the new normal? European Journal of Clinical Pharmacology, 70(11), 1403-1404. doi: 10.1007/s00228-014-1740-8

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H. S. (2014). Integrating a PKPD computer simulation in the BPharm course. Proceedings of the 16th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/dunedin-2014/

Al-Sallami, H. S. (2014). Redefining normal variability of drug disposition. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 35). Retrieved from http://www.asceptasm.com/

Conference Contribution - Verbal presentation and other Conference outputs

Al-Sallami, H. (2014, August). Integrating a pharmacokinetic-pharmacodynamic computer simulation in the BPharm course. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2013

Journal - Research Other

Wright, D. F. B., Al-Sallami, H. S., & Duffull, S. B. (2013). Is the dose of dabigatran really more predictable than warfarin? British Journal of Clinical Pharmacology, 76(6), 997-998. doi: 10.1111/bcp.12144

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H., Goulding, A., Williams, S., Grant, A., Taylor, R., & Duffull, S. (2013). Estimating fat-free mass in children. Proceedings of the Paediatric Society of New Zealand 65th Annual Scientific Meeting. (pp. 71). Retrieved from http://www.psnz2013.co.nz/

Al-Sallami, H. S., Barras, M., & Duffull, S. B. (2013). Evaluation of a Bayesian dose-individualisation method for enoxaparin. Proceedings of the Twenty-second Annual Meeting of the Population Approach Group in Europe (PAGE). 2818. Retrieved from http://www.page-meeting.org/default.asp?abstract=2818

Tordoff, J., Browne, D., & Al-Sallami, H. S. (2013). Examining antipsychotic use in residents in dementia and psychogeriatric units in New Zealand. International Journal of Pharmacy Practice, 21(Suppl. 1), (pp. 9). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Duffull, S., Al-Sallami, H., & Wright, D. (2013, December). When EBM meets clinical practice. Workshop presentation at the Australasian Pharmaceutical Science Association (APSA) Conference, Dunedin, New Zealand.

Al-Sallami, H. S., Cheah, S., Han, S., Liew, J., Lim, J., Ng, M., Solanki, H., Soo, R., & Tan, V. (2013, August). How predictable are pharmacokinetic parameters? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2012

Journal - Research Article

Loke, S.-K., Al-Sallami, H. S., Wright, D. F. B., McDonald, J., Jadhav, S., & Duffull, S. B. (2012). Challenges in integrating a complex systems computer simulation in class: An educational design research. Australasian Journal of Educational Technology, 28(4), 671-683. doi: 10.14742/ajet.834

Journal - Research Other

Duffull, S. B., Wright, D. F. B., Al-Sallami, H. S., Zufferey, P. J., & Faed, J. M. (2012). Dabigatran: Rational dose individualisation and monitoring guidance is needed. New Zealand Medical Journal, 125(1357). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H. S., Barras, M., & Duffull, S. B. (2012). Evaluation of a Bayesian dose-individualisation method for enoxaparin. Proceedings of the 14th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/conference/melbourne-2012-14th-annual-scientific-meeting

Conference Contribution - Poster Presentation (not in published proceedings)

Al-Sallami, H. S., Barras, B., & Duffull, S. B. (2012, August-September). Evaluation of a dose-individualisation method for enoxaparin. Poster session presented at the New Zealand Hospital Pharmacists' Association Conference, Auckland, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Al-Sallami, H. S., Goulding, A., Taylor, R., Grant, A., Williams, S., & Duffull, S. B. (2012, August-September). Estimating fat-free mass in children. Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Auckland, New Zealand.

2011

Journal - Research Article

Wright, D. F. B., Pavan Kumar, V. V., Al-Sallami, H. S., & Duffull, S. B. (2011). The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: Simulations from a pharmacokinetic—pharmacodynamic model. Basic & Clinical Pharmacology & Toxicology, 109(6), 494-498. doi: 10.1111/j.1742-7843.2011.00757.x

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H. S., Goulding, A., Taylor, R., Grant, A., Williams, S., & Duffull, S. B. (2011). Estimating fat-free mass in children. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Carney Symposium: New Zealand Annual Scientific Meeting. 2.3. Retrieved from http://www.otago.ac.nz/asceptnz/docs/programme.pdf

Al-Sallami, H. S., Goulding, A., Taylor, R. W., Grant, A. M., Williams, S. M., & Duffull, S. B. (2011). A semi-mechanistic model for estimating fat free mass in children. Proceedings of the Twentieth Annual Meeting of the Population Approach Group in Europe. PAGE. Retrieved from http://www.page-meeting.org/?abstract=2063

Wright, D. F. B., Pavan Kumar, V. V., Al-Sallami, H. S., & Duffull, S. B. (2011). The use of PKPD simulations to inform the rational use of medicines in clinical practice: The case of simvastatin circadian dosing. Proceedings of the Population Approach Group in Australia and New Zealand Meeting (PAGANZ). PAGANZ. Retrieved from http://www.paganz.org/default.asp?id=45&keuze=program

Conference Contribution - Verbal presentation and other Conference outputs

Wright, D. F. B., Kumar, V. V. P., Al-Sallami, H. S., & Duffull, S. B. (2011, November). Is simvastatin really more effective when taken in the evening? Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Tauranga, New Zealand.

Al-Sallami, H. S., Wright, D. F. B., Loke, S. K., McDonald, J., Jadhav, S., & Duffull, S. B. (2011, November). Coagusim: A new teaching tool to simulate the time course of INR effects of warfarin. Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Tauranga, New Zealand.

2010

Journal - Research Article

Wright, D. F. B., Al-Sallami, H. S., Jackson, P. M., & Reith, D. M. (2010). Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths). British Journal of Clinical Pharmacology, 70(5), 769-772. doi: 10.1111/j.1365-2125.2010.03749.x

Al-Sallami, H. S., Barras, M. A., Green, B., & Duffull, S. B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49(9), 567-571. doi: 10.2165/11532960-000000000-00000

Journal - Research Other

Al-Sallami, H., Jordan, S., Ferguson, R., Medlicott, N. J., Schollum, J., & Duffull, S. B. (2010). Current enoxaparin dosing guidelines have dubious credibility [Viewpoint]. New Zealand Medical Journal, 123(1313). Retrieved from http://journal.nzma.org.nz/journal/123-1313/4076/content.pdf

Conference Contribution - Published proceedings: Abstract

Wright, D. F. B., Kumar Vajjah, V. P., Al-Sallami, H. S., & Duffull, S. B. (2010). Is simvastatin really more effective when taken in the evening? Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/

Al-Sallami, H. S., Barras, M. A., Green, B., & Duffull, S. B. (2010). A rationale for the routine monitoring of anti-activated factor X (anti-Xa) during enoxaparin treatment. Proceedings of the Nineteenth Annual Meeting of the Population Approach Group in Europe. PAGE. Retrieved from http://www.page-meeting.org/default.asp?abstract=1791

Al-Sallami, H. S., & Duffull, S. B. (2010). Developing a model for estimating lean body weight in children. Proceedings of the 12th Annual Population Approach Group in Australia and New Zealand Conference (PAGANZ 10). PAGANZ. Retrieved from http://www.paganz.org/default.asp?id=44&keuze=abstracts&orderby=author

Other Research Output

Al-Sallami, H. (2010, November). CoaguSim: A novel teaching tool for pharmacy education. University of Otago School of Pharmacy Seminar. Dunedin, New Zealand. [Department Seminar].

2009

Journal - Research Article

Al-Sallami, H. S., Kumar, V. V. P., Landersdorfer, C. B., Bulitta, J. B., & Duffull, S. B. (2009). The time course of drug effects. Pharmaceutical Statistics, 8, 176-185. doi: 10.1002/pst.393

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H., Duffull, S., & Schollum, J. (2009). A case for routine monitoring of enoxaparin treatment. Proceedings of the 11th Annual Population Approach Group in Australia and New Zealand Conference. PAGANZ. Retrieved from http://www.paganz.org/default.asp?abstract=1092

Conference Contribution - Poster Presentation (not in published proceedings)

Al-Sallami, H., Duffull, S., & Schollum, J. (2009, November). A rationale for the routine monitoring of anti-Xa concentration during enoxaparin treatment. Poster session presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, Los Angles, USA.

Conference Contribution - Verbal presentation and other Conference outputs

Al-Sallami, H., La, S., Moon, J., Noh, L., Yeat, N., & Medlicott, N. (2009, September). Assessing the physical stability of drug combinations in subcutaneous syringes. Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Nelson, New Zealand.

Al-Sallami, H., Bell, N., Smith, A., Stevenson, J., Young, S., & Duffull, S. (2009, September). Evidence-based clinical pharmacy services in New Zealand hospitals. Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Nelson, New Zealand.

Al-Sallami, H. S., Jordan, S., Ferguson, R., Medlicott, N. J., Schollum, J., & Duffull, S. B. (2009, September). Are enoxaparin dosing guidelines credible? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

2008

Journal - Research Article

Al-Sallami, H., Ferguson, R., Wilkins, G., Gray, A., & Medlicott, N. J. (2008). Bleeding events in patients receiving enoxaparin for the management of non-ST-elevation acute coronary syndrome (NSTEACS) at Dunedin Public Hospital, New Zealand. New Zealand Medical Journal, 121(1285). Retrieved from http://journal.nzma.org.nz/journal/121-1285/3342/content.pdf

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H. S., Duffull, S. B., & Schollum, J. (2008). Enoxaparin: Identifying a treatment target. Proceedings of the 4th Australian Health and Medical Research Congress. (pp. 167). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Al-Sallami, H., Duffull, S., & Schollum, J. (2008, September). Enoxaparin: Optimising therapy through target concentration intervention. Verbal presentation at the New Zealand Healthcare Pharmacists' Association Conference, Auckland, New Zealand.

2007

Conference Contribution - Poster Presentation (not in published proceedings)

Al-Sallami, H., Ferguson, R., Medlicott, N., Wilkins, G., & Gray, A. (2007, August). Incidents and predictors of bleeding in non-st-elevation acute coronary syndrome patients treated with enoxaparin. Poster session presented at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (NZ) Annual Scientific Meeting, Auckland, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Al-Sallami, H., Ferguson, R., Medlicott, N., & Wilkins, G. (2007, September). Bleeding associated with enoxaparin in patients treated for non-ST-elevation acute coronary syndrome at Dunedin Hospital. Verbal presentation at the New Zealand HealthCare Pharmacists' Association Conference, Wellington, New Zealand.

2001

Journal - Research Article

Al-Sallami, H., Ball, P. A., & Davey, A. (2001). Metered-dose inhaler with spacer versus nebuliser for acute exacerbation of asthma - a literature review. Australian Journal of Hospital Pharmacy, 31(3), 189-192.

2000

Conference Contribution - Published proceedings: Abstract

Al-Sallami, H., Ball, P. A., & Davey, A. (2000). Aerosolised drug delivery devices in human airway disease - a literature review. Proceedings of the New Zealand Healthcare Pharmacists Association Annual Congress. (pp. 28). Auckland. [Abstract]

Al-Sallami, H., Ball, P. A., Davey, A., Napier, P., Fitzgerald, C., & Gardner, R. (2000). Design and development of a standard operating procedure for nebuliser use at Dunedin Hospital. Proceedings of the New Zealand Healthcare Pharmacists Association Annual Congress. (pp. 27). Auckland. [Abstract]